IRCT138708131431N1CompletedPhase 3
Comparative Clinical Trial of Mebendazole, Praziquantel and Metronidazole in treatment of human Giardiasis
Conditions
Trial Snapshot
- Phase
- Phase 3
- Status
- Completed
- Enrollment
- 600
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 2 years to 30 years (—)
- Sex
- All
Inclusion Criteria
- •Patients with gastrointestinal complaints including diarrhea; weight loss; anorexia or fatigue and positive for Giardaisis. Exclusion criteria: Drug side effects; Immune deficiency; consumption of current antibiotic.
Exclusion Criteria
- Not provided
Investigators
Similar Trials
Completed
Phase 3
Mebendazole compared with secnidazole-adult giardiasis-Phase IIIGiardiasisRPCEC00000095Central Military Hospital Carlos J. Finlay110
Completed
Phase 3
A Study to Assess the Efficacy and Safety of Mebendazole for the Treatment of Helminth Infections in Pediatric ParticipantsHelminth InfectionsNCT02034162Janssen Research & Development, LLC295
Recruiting
Not Applicable
Effects of Mebendazole to Lenvatinib (drug) in liver cancerCTRI/2020/06/026240Institute of Liver and Biliary Sciences
Completed
Phase 4
Study to Evaluate Efficacy and Safety of a Double Treatment Plan Using a Combination of Mebendazole and Quinfamide for Treating Intestinal Helminthiasis and Amebiasis in the Mexican PopulationAmoebiasisHelminthiasisNCT02385058Janssen-Cilag Ltd.100
Completed
Not Applicable
Comparative efficacy of albendazole and mebendazole against hookworm infection in LaosISRCTN29126001Swiss National Science Foundation (Switzerland)190